Preferred pharmaceutical-grade opioids to reduce the use of unregulated opioids: A cross-sectional analysis among people who use unregulated opioids in Vancouver, Canada.  Speed KA, Choi J, Felicella G, Sedgemore KO, Mok WY, Milloy MJ, DeBec...

Medications for opioid use disorder: Predictors of early discontinuation and reduction of overdose risk in US military veterans by medication type.  Hayes CJ, Raciborski RA, Nowak M, Acharya M, Nunes EV Jr, Winhusen TJ.  Addiction. 202...

A qualitative evaluation of a fentanyl patch safer supply program in Vancouver, Canada.  Norton A, Ivsins A, Holliday E, Sutherland C, Kerr T, Kennedy MC.  Int J Drug Policy. 2024 Aug 17;131:104547. doi: 10.1016/j.drugpo.2024.104547. E...

Healthcare utilisation and associated costs for methadone versus buprenorphine recipients: Examination of interlinked primary and secondary care electronic health records in England.  Domzaridou E, Allen T, Carr MJ, Millar T, Webb RT, Ashcro...

Traitements par agonistes opioïdes (TAO) et à la diacétylmorphine (DAM) : similitudes et différences de ces approches thérapeutiques.  Substitut Amos J., Gmel G. (2024).  BRENNPUNKT | ÉCLAIRAGE 2024. Addiction Suisse. doi: 10.58758/ecl...

The effect of a pilot brief educational intervention on preferences regarding treatments for opioid use disorder.  Irani E, Macleod C, Slat S, Kehne A, Madden E, Jaffe K, Bohnert A, Lagisetty P.  Drug Alcohol Depend Rep. 2024 Apr 24;11...